StonvexLoading…
StonvexStonvexStonvexCore line items from MNTK's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $176.38M | $175.74M | $174.90M | $213.39M |
Operating Income | $852.00K | $16.12M | $23.64M | $44.57M |
Net Income | $1.75M | $9.73M | $14.95M | $35.19M |
EPS (Diluted) | $0.01 | $0.07 | $0.11 | $0.25 |
Total Assets | $435.46M | $349.01M | $350.24M | $332.32M |
Total Liabilities | $172.31M | $91.60M | $100.00M | $105.22M |
Cash & Equivalents | $23.75M | $45.62M | $73.81M | $105.18M |
Free Cash Flow OCF − CapEx | $-86.21M | $-18.53M | $-22.04M | $58.79M |
Shares Outstanding | 143.24M | 142.71M | 141.99M | 141.63M |